APA (7th ed.) Citation

Simó, R., Guerci, B., Schernthaner, G., Gallwitz, B., Rosas-Guzmàn, J., Dotta, F., . . . Kiljański, J. (2015). Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: Results from the European exenatide study. Cardiovascular diabetology, 14(1), 116. https://doi.org/10.1186/s12933-015-0279-z

Chicago Style (17th ed.) Citation

Simó, Rafael, Bruno Guerci, Guntram Schernthaner, Baptist Gallwitz, Juan Rosas-Guzmàn, Francesco Dotta, Andreas Festa, Ming Zhou, and Jacek Kiljański. "Long-term Changes in Cardiovascular Risk Markers During Administration of Exenatide Twice Daily or Glimepiride: Results from the European Exenatide Study." Cardiovascular Diabetology 14, no. 1 (2015): 116. https://doi.org/10.1186/s12933-015-0279-z.

MLA (9th ed.) Citation

Simó, Rafael, et al. "Long-term Changes in Cardiovascular Risk Markers During Administration of Exenatide Twice Daily or Glimepiride: Results from the European Exenatide Study." Cardiovascular Diabetology, vol. 14, no. 1, 2015, p. 116, https://doi.org/10.1186/s12933-015-0279-z.